ARCHIVES

FDA Authority To Remove Paclitaxel Patent Questioned.

This article is from The Cancer Letter archive.

Vol. 27 No. 06 | February 9, 2001

Download PDF Visit The Full Archive

Related Articles

Propac To Recommend Reclassification Of Five Leukemia/Lymphoma Diagnosis Related Groups

March 21, 1986

NIH Reauthorization Threatened By Fetal Research Issue

October 5, 1990

Expiring Program Offer Flexibility

February 12, 1982

ACS President Lawrence Emphasizes Prevention Gains Since 1971

April 10, 1992

Core Grant Guideline Revisions, Comprehensive Center Characteristics Changes Still Coming Up

July 13, 1979

Heidelberger Wins $100,000 Award

September 17, 1982